232 related articles for article (PubMed ID: 9721427)
1. Therapeutic drug monitoring of cyclosporine and tacrolimus. Update on Lake Louise Consensus Conference on cyclosporin and tacrolimus.
Oellerich M; Armstrong VW; Schütz E; Shaw LM
Clin Biochem; 1998 Jul; 31(5):309-16. PubMed ID: 9721427
[No Abstract] [Full Text] [Related]
2. Role of immunophilins in therapeutic drug monitoring of immunosuppressive drugs.
Soldin SJ
Clin Biochem; 1998 Jul; 31(5):381-4. PubMed ID: 9721438
[No Abstract] [Full Text] [Related]
3. Therapeutic monitoring of tacrolimus in pediatric and adult transplanted patients.
Capone D; Gentile A; Vajro P; Stanziale P; Imperatore P; De Silva C; Pellegrino T; Basile V
J Chemother; 1998 Apr; 10(2):176-8. PubMed ID: 9603651
[No Abstract] [Full Text] [Related]
4. Calcineurin Inhibitor Determination in Whole Blood With the RXL Dimension Analyzer: A Useful Tool for Immunosuppressive Drug Monitoring.
Ventura E; Bonardet A; Pageaux GP; Mourad G; Cristol JP
Transplant Proc; 2009 Mar; 41(2):707-9. PubMed ID: 19328963
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic drug monitoring of tacrolimus early after liver transplantation.
Braun F; Peters B; Schütz E; Lorf T; Undre N; Oellerich M; Ringe B
Transplant Proc; 2002 Aug; 34(5):1538-9. PubMed ID: 12176473
[No Abstract] [Full Text] [Related]
6. Neoral C2 monitoring in solid organ transplantation.
Levy GA
Transplant Proc; 2004 Mar; 36(2 Suppl):392S-395S. PubMed ID: 15041373
[No Abstract] [Full Text] [Related]
7. Specificity of therapeutic drug monitoring of tacrolimus in kidney transplant patients.
Sato S; Fuchinoue S; Tojimbara T; Fujita S; Nakajima I; Agishi T; Hayashi T; Teramura Y; Fujita E; Iwasaki K
Transplant Proc; 1998 Jun; 30(4):1274-5. PubMed ID: 9636517
[No Abstract] [Full Text] [Related]
8. Telaprevir, boceprevir, cytochrome P450 and immunosuppressive agents--a potentially lethal cocktail.
Charlton M
Hepatology; 2011 Jul; 54(1):3-5. PubMed ID: 21710471
[No Abstract] [Full Text] [Related]
9. Clinical relevance of monitoring tacrolimus: comparison of microparticle enzyme immunoassay, enzyme-linked immunosorbent assay, and liquid chromatography mass spectrometry in renal transplant recipients converted from cyclosporine to tacrolimus.
Braun F; Lorf T; Schütz E; Christians U; Grupp C; Sattler B; Canelo R; Sewing KF; Armstrong VW; Oellerich M; Ringe B
Transplant Proc; 1996 Dec; 28(6):3175-6. PubMed ID: 8962231
[No Abstract] [Full Text] [Related]
10. Experience with the use of basiliximab in liver transplantation--use in pediatric and adult recipients in combination with cyclosporine or tacrolimus.
Petz W; Spada M; Bertani A; Lucianctti A; Casagrande F; Guizzetti M; Corno V; Colledan M; Strazzabosco M; Gridelli B
Transplant Proc; 2002 Aug; 34(5):1966-7. PubMed ID: 12176648
[No Abstract] [Full Text] [Related]
11. Lake Louise Consensus Conference on cyclosporin monitoring in organ transplantation: report of the consensus panel.
Oellerich M; Armstrong VW; Kahan B; Shaw L; Holt DW; Yatscoff R; Lindholm A; Halloran P; Gallicano K; Wonigeit K
Ther Drug Monit; 1995 Dec; 17(6):642-54. PubMed ID: 8588235
[No Abstract] [Full Text] [Related]
12. A transient increase of calcineurin phosphatase activity in living-donor kidney transplant recipients with acute rejection.
Fukudo M; Yano I; Katsura T; Ito N; Yamamoto S; Kamoto T; Ogawa O; Inui K
Drug Metab Pharmacokinet; 2010; 25(5):411-7. PubMed ID: 20834189
[TBL] [Abstract][Full Text] [Related]
13. Tacrolimus vs CyA Neoral in combination with MMF and steroids after cadaveric renal transplantation.
Wang XH; Tang XD; Xu D
Transplant Proc; 2000 Nov; 32(7):1702-3. PubMed ID: 11119899
[No Abstract] [Full Text] [Related]
14. Elevated tacrolimus levels during diarrhea in children after liver transplantation.
Teisseyre J; Teisseyre M; Kalicinski P; Ismail H; Drewniak T; Kaminski A; Pawlowska J
Transplant Proc; 2003 Sep; 35(6):2292-4. PubMed ID: 14529919
[No Abstract] [Full Text] [Related]
15. Cyclosporine A: peak or trough level monitoring in renal transplant recipients?
Wacke R; Drewelow B; Kundt G; Hehl EM; Bast R; Seiter H
Transplant Proc; 2001; 33(7-8):3122-3. PubMed ID: 11750342
[No Abstract] [Full Text] [Related]
16. Conversion of C-0 to C-2 monitoring of cyclosporine in stable kidney transplant patients.
Jirasiritham S; Mavichak V; Danviriyasup K; Jirasiritham S
Transplant Proc; 2003 Feb; 35(1):236-7. PubMed ID: 12591379
[No Abstract] [Full Text] [Related]
17. Usefulness of monitoring of AUC(0-4h) during the induction period of immunosuppressive therapy with tacrolimus after renal transplantation.
Uchida K; Tominaga Y; Haba T; Katayama T; Matsuoka S; Sato T; Goto N; Takeda A; Morozumi K; Takagi H
Transplant Proc; 2002 Aug; 34(5):1736-7. PubMed ID: 12176556
[No Abstract] [Full Text] [Related]
18. Cyclosporine level: which single-point estimation of drug level is the best?
Sharma R; Kumar J; Ahmed M; Gupta A; Gulati S; Sharma AP; Bhandari M
Transplant Proc; 2001; 33(7-8):3124-5. PubMed ID: 11750343
[No Abstract] [Full Text] [Related]
19. The roles of C4 and AUC0-4 in monitoring of tacrolimus in stable kidney transplant patients.
Pisitkun T; Eiam-Ong S; Chusil S; Praditpornsilpa K; Pansin P; Tungsanga K
Transplant Proc; 2002 Dec; 34(8):3173-5. PubMed ID: 12493410
[No Abstract] [Full Text] [Related]
20. Successful reconversion from tacrolimus to cyclosporine A Neoral in pediatric liver recipients.
Melter M; Rodeck B; Kardorff R; Hoyer PF; Maibücher A; Brodehl J
Transplant Proc; 1996 Aug; 28(4):2276-8. PubMed ID: 8769224
[No Abstract] [Full Text] [Related]
[Next] [New Search]
